Brain+ ApS Market Cap ($744.48K)
Market Cap & Net Worth: Brain+ ApS (BRAINP)
Brain+ ApS market cap. Brain+ ApS (CO:BRAINP) has a market capitalization of $744.48K (Dkr4.76 Million) as of November 4, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #30844 globally and #146 in its home market, demonstrating a 23.53% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brain+ ApS's stock price Dkr0.00 by its total outstanding shares 1132939014 (1.13 Billion). Also see how efficiently does Brain+ ApS generate cash for how efficiently the company converts equity into cash flow.
Brain+ ApS Market Cap History (2021–2026)
Brain+ ApS market cap history from 2021 to 2026. Data shows change from $606.22 Million to $744.48K (-78.79% CAGR). Check Brain+ ApS share price for real-time trading data and today's change.
Brain+ ApS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brain+ ApS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore BRAINP year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.12x
Brain+ ApS's market cap is 2.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $606.22 Million | $3.99 Million | -$7.08 Million | 151.85x | N/A |
| 2022 | $303.11 Million | $2.64 Million | -$9.68 Million | 114.68x | N/A |
| 2023 | $34.39 Million | $2.35 Million | -$19.12 Million | 14.62x | N/A |
| 2024 | $16.63 Million | $7.86 Million | -$12.05 Million | 2.12x | N/A |
Competitor Companies of BRAINP by Market Capitalization
Companies near Brain+ ApS in the global market cap rankings as of November 4, 2026. Also see Brain+ ApS balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Brain+ ApS by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #718 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1660 globally with a market cap of $14.14 Billion USD ( AU$19.99 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2013 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #718 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $303.21 |
| #1660 | Pro Medicus Ltd | AU:PME | $14.14 Billion | AU$191.33 |
| #2013 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $77.80 |
| #2073 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $69.84 |
Market Capitalization of Brain+ ApS (2021–2026)
Market capitalization of Brain+ ApS from 2021 to today. Between 2021 and today, Brain+ ApS's market cap moved from $606.22 Million to $ 744.48K, with a yearly change of -78.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr744.48K | -58.00% |
| 2025 | Dkr1.77 Million | -89.34% |
| 2024 | Dkr16.63 Million | -51.65% |
| 2023 | Dkr34.39 Million | -88.65% |
| 2022 | Dkr303.11 Million | -50.00% |
| 2021 | Dkr606.22 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Brain+ ApS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $744.48K USD |
| MoneyControl | $744.48K USD |
| MarketWatch | $744.48K USD |
| marketcap.company | $744.48K USD |
| Reuters | $744.48K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more